Real-time enrollment status for this graft-versus-host disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:47 AM UTC
| NCT Number | NCT06619561 |
| Recruiting Status | Recruiting |
| Condition | Graft-Versus-Host Disease |
| Phase | Clinical Trial |
| Target Enrollment | 36 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Deciphera Pharmaceuticals, LLC |
| Last Updated on CT.gov | December 15, 2025 (Dec 15, 2025) |
As of March 2, 2026: Clinical trial NCT06619561 is currently recruiting participants. This clinical trial study for graft-versus-host disease is actively seeking new participants at 19 locations across the United States. The study is sponsored by Deciphera Pharmaceuticals, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06619561 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06619561 was last updated Dec 15, 2025 (December 15, 2025). HelloStudys verifies this status automatically.